✦ LIBER ✦

Sirolimus Reduces the Risk of Significant Hepatic Fibrosis After Liver Transplantation for Hepatitis C Virus: A Single-Center Experience

✍ Scribed by Kelly, M.A.; Kaplan, M.; Nydam, T.; Wachs, M.; Bak, T.; Kam, I.; Zimmerman, M.A.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sirolimus reduces the risk of significan

✍ Mara A. Kelly; Maria Kaplan; Maxwell L. Smith; Michael Wachs; Thomas Bak; Igal K 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Survival and Hepatitis C Virus Recurrenc

✍ M. Testillano; J.R. Fernandez; M.J. Suarez; M. Gastaca; J. Bustamante; J.I. Pijo 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 520 KB

498 NATURAL HISTORY OF HEPATITIS C AFTER

✍ A. Yosephy; J.F. Gallegos-Orozco; T.J. Byrne; B. Noble; B. Aqel; E. Carey; D.D. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Telbivudin as Prophylaxis for Hepatitis

✍ Perrella, A.; Lanza, A. Galeota; Santaniello, W.; Pisaniello, D.; DiCostanzo, G. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 245 KB

Antiviral Therapy for Hepatitis C Virus

✍ P. Burra; S. Targhetta; S. Pevere; S. Boninsegna; M. Guido; D. Canova; A. Broles 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 70 KB

148 Impact of pegylated interferon alfa-

✍ Sandeep Mukherjee; Richard K. Gilroy; Joyce Rogge; Lynne Weaver; Timothy M. McCa 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB